Spinal cord transection and subsequent treatment with cyclophosphamide or isobutyl-2-cyanocrylate: associated microvascular abnormalities.
D000818:Animals; D002015:Bucrylate / Q000627:therapeutic use*; D002921:Cicatrix / Q000473:pathology; D003487:Cyanoacrylates / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004727:Endothelium / Q000648:ultrastructure; D008833:Microcirculation / Q000648:ultrastructure; D008854:Microscopy, Electron; D009130:Muscle, Smooth / Q000648:ultrastructure; D051381:Rats; D013116:Spinal Cord / Q000098:blood supply / Q000473:pathology*; D013119:Spinal Cord Injuries / Q000473:pathology*
D003487:Cyanoacrylates; D002015:Bucrylate; D003520:Cyclophosphamide